Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Galapagos (GLPG – Research Report) and Immunocore Holdings (IMCR – Research Report).
Galapagos (GLPG)
In a report released yesterday, Matthew Harrison from Morgan Stanley maintained a Hold rating on Galapagos, with a price target of $40.00. The company’s shares closed last Monday at $38.84, close to its 52-week low of $36.17.
According to TipRanks.com, Harrison is a 5-star analyst with an average return of
Currently, the analyst consensus on Galapagos is a Hold with an average price target of $41.75, representing a 5.4% upside. In a report issued on August 7, RBC Capital also maintained a Hold rating on the stock with a $38.00 price target.
See today’s best-performing stocks on TipRanks >>
Immunocore Holdings (IMCR)
In a report released yesterday, Andrew Galler from Morgan Stanley maintained a Buy rating on Immunocore Holdings, with a price target of $79.00. The company’s shares closed last Monday at $59.86.
Galler has an average return of
According to TipRanks.com, Galler is ranked #2948 out of 8522 analysts.
Currently, the analyst consensus on Immunocore Holdings is a Strong Buy with an average price target of $81.22, implying a 38.0% upside from current levels. In a report issued on August 16, Capital One Financial also initiated coverage with a Buy rating on the stock with a $84.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on GLPG:
